Regeneron Pharmaceuticals, Inc. Share Price Today: Live Updates & Key Insights
Regeneron Pharmaceuticals, Inc. share price today is $736.44, up -0.62%. The stock opened at $740.255 against the previous close of $737.45, with an intraday high of $744.08 and low of $729.
Regeneron Pharmaceuticals, Inc. Share Price Chart
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Share Price Performance
Regeneron Pharmaceuticals, Inc. Institutional Holdings
Regeneron Pharmaceuticals, Inc. Market Status
Regeneron Pharmaceuticals, Inc. Fundamentals
Market Cap 77478.88 M
PB Ratio 2.4788
PE Ratio 17.668
Enterprise Value 71579.57 M
Total Assets 40558.70 M
Volume 1359993
Regeneron Pharmaceuticals, Inc. Company Financials
About Regeneron Pharmaceuticals, Inc. & investment objective
Company Information Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of prematurity; Dupixent injection to treat atopic dermatitis and asthma; Libtayo injection for metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection to treat heterozygous familial hypercholesterolemia (HoFH); and Kevzara solution for rheumatoid arthritis. It has license and collaboration agreement with Bayer for the development and commercialization of EYLEA 8 mg and EYLEA; Alnylam Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for diseases by addressing therapeutic disease targets expressed in the eye and central nervous system; Intellia Therapeutics, Inc. to advance CRISPR/Cas9 gene-editing technology for in vivo therapeutic development for therapies focused on neurological and muscular diseases; Hansoh Pharmaceuticals Group Company Limited to acquire development and commercial rights for HS-20094, a dual GLP-1/GIP receptor; and Tessera Therapeutics, Inc. develops and commercializes TSRA-196, an investigational gene editing therapy for Alpha-1 antitrypsin deficiency. The company was incorporated in 1988 and is based in Tarrytown, New York.
Organisation Biotechnology
Employees 15410
Industry Biotechnology
CEO Dr. Leonard S. Schleifer M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Regeneron Pharmaceuticals, Inc. FAQs
What is the share price of Regeneron Pharmaceuticals, Inc. today?
The current share price of Regeneron Pharmaceuticals, Inc. is $736.44.
Can I buy Regeneron Pharmaceuticals, Inc. shares in India?
Yes, Indian investors can buy Regeneron Pharmaceuticals, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Regeneron Pharmaceuticals, Inc. shares in India?
You can easily invest in Regeneron Pharmaceuticals, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Regeneron Pharmaceuticals, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Regeneron Pharmaceuticals, Inc..
Can I buy fractional shares of Regeneron Pharmaceuticals, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. has a market cap of $77478.88 M.
In which sector does Regeneron Pharmaceuticals, Inc. belong?
Regeneron Pharmaceuticals, Inc. operates in the Biotechnology sector.
What documents are required to invest in Regeneron Pharmaceuticals, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Regeneron Pharmaceuticals, Inc.?
The PE ratio of Regeneron Pharmaceuticals, Inc. is 17.67 and the PB ratio is 2.48.